206 related articles for article (PubMed ID: 9864794)
21. [Immunological status of women with HL-A and rhesus sensitization].
Zaĭtseva GA; Voronchikhina LD; Drabert ED; Strazhnikova GA; Vozhegova NP
Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):35-7. PubMed ID: 6775315
[No Abstract] [Full Text] [Related]
22. Cardiovascular complications of diabetes.
Lau DC; Shen GX
Can J Diabetes; 2013 Oct; 37(5):279-81. PubMed ID: 24500552
[No Abstract] [Full Text] [Related]
23. [Effect of glycemic equilibrium on micro-angiopathic complications in insulin-dependent diabetes: results of recent studies].
Zinman B
Journ Annu Diabetol Hotel Dieu; 1994; ():93-100. PubMed ID: 8051834
[No Abstract] [Full Text] [Related]
24. [Quantitative changes of the blood serum immunoglobulins in patients with diabetes mellitus types I and II and microangiopathy detected by morphologic study].
Saltykov BB; Velikov VK; Tarasov VK; Pershin BB; Kuz'min SN; Shubina OI; Frolova AI; Zelenchuk NM; Shepkova TP
Ter Arkh; 1990; 62(4):111-4. PubMed ID: 2392748
[TBL] [Abstract][Full Text] [Related]
25. The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus.
Akbay E; Yetkin I; Ersoy R; Kulaksizoğlu S; Törüner F; Arslan M
Diabetes Nutr Metab; 2004 Dec; 17(6):331-5. PubMed ID: 15887626
[TBL] [Abstract][Full Text] [Related]
26. [The effect of the type of diabetes,the HLA type and metabolic status on cellular immunity in diabetic patients].
Zamaklar M; Devecerski M; Petrović M; Andjeloković S; Drezgić M
Glas Srp Akad Nauka Med; 1985; (37):69-75. PubMed ID: 3842683
[No Abstract] [Full Text] [Related]
27. Symposium on treatment of diabetic complications. 5. Strict glycemic control and diabetic microvascular complications.
Shichiri M
Intern Med; 1997 Feb; 36(2):144-7. PubMed ID: 9099605
[No Abstract] [Full Text] [Related]
28. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
[TBL] [Abstract][Full Text] [Related]
29. [Status of cellular immunity in diabetic microangiopathy detected by skin biopsy].
Ermakova NG; Saltykov BB; Velikov VK; Shubina OI; Frolova AI
Ter Arkh; 1986; 58(10):94-7. PubMed ID: 3492060
[TBL] [Abstract][Full Text] [Related]
30. [Diabetic microangiopathy: does a genetic susceptibility HLA-correlated exist?].
Scaldaferri E; Devidè A
Minerva Endocrinol; 1985; 10(2):115-24. PubMed ID: 3906376
[No Abstract] [Full Text] [Related]
31. Immunity in diabetes mellitus.
Narang NK; Gupta RC; Singh N
J Assoc Physicians India; 1989 Sep; 37(9):614. PubMed ID: 2632568
[No Abstract] [Full Text] [Related]
32. [Role of dysgammaglobulinemia in evaluation of severity of diabetes and sensitivity to insulin in children with diabetes mellitus].
Dreval' AV; Zhukovskiĭ MA; Mikhaĭlova VS; Shcherbacheva LN; Malkina LA
Sov Med; 1976 Jun; (6):36-40. PubMed ID: 1019722
[No Abstract] [Full Text] [Related]
33. Genetic heterogeneity in diabetes mellitus and diabetic microangiopathy.
Rimoin DL; Rotter JI
Horm Metab Res Suppl; 1981; 11():63-72. PubMed ID: 6947951
[TBL] [Abstract][Full Text] [Related]
34. [Morphofunctional changes in the erythrocytes in diabetes mellitus].
Efimov AS; Pleshanov EV; Gogina IF
Probl Endokrinol (Mosk); 1988; 34(2):13-5. PubMed ID: 3393498
[TBL] [Abstract][Full Text] [Related]
35. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
Haffner SM
Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein (a): role in diabetes and its vascular complications.
Mohan A; Srinivasan V; Deepa R; Mohan V
J Assoc Physicians India; 2001 Nov; 49():1100-5. PubMed ID: 11868866
[No Abstract] [Full Text] [Related]
37. [Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?].
Pawłowski P; Urban M; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):147-52. PubMed ID: 16232368
[TBL] [Abstract][Full Text] [Related]
38. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
Diabetes Reserach in Children Network (DirecNet) Study Group
Diabetes Care; 2007 Jan; 30(1):185; author reply 187-9. PubMed ID: 17192364
[No Abstract] [Full Text] [Related]
39. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
Service FJ; O'Brien PC
Diabetes Care; 2007 Jan; 30(1):186; author reply 187-8. PubMed ID: 17192366
[No Abstract] [Full Text] [Related]
40. [New aspects in the pathogenesis and in the course of type-I-diabetes mellitus (author's transl)].
Schernthaner G
Wien Klin Wochenschr Suppl; 1980; 114():1-36. PubMed ID: 6254277
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
